Home  >  Products  >  SRC (v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) ) Blocking Peptide (the N terminal of SRC)(100ug)
SRC (v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) ) Blocking Peptide (the N terminal of SRC)(100ug)

SRC (v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) ) Blocking Peptide (the N terminal of SRC)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SRC Antibody (ARP32476_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAPY04406
Size: 100ug
Weight: 60kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene is highly similar to the v-src gene of Rous sarcoma virus. This proto-oncogene may play a role in the regulation of embryonic development and cell growth. SRC protein is a tyrosine-protein kinase whose activity can be inhibited by phosphorylation by c-SRC kinase. Mutations in this gene could be involved in the malignant progression of colon cancer.
Alternative names: ASV; SRC1; c-SRC; p60-Src
See Full Product Listings >